DekaBank Deutsche Girozentrale decreased its position in Zymeworks Inc. (NYSE:ZYME – Free Report) by 70.5% during the 4th quarter, according to its most recent filing with the SEC. The institutional investor owned 3,843 shares of the company’s stock after selling 9,191 shares during the period. DekaBank Deutsche Girozentrale’s holdings in Zymeworks were worth $40,000 as […]
Shares of Zymeworks Inc. (NYSE:ZYME – Get Free Report) reached a new 52-week high during mid-day trading on Tuesday . The company traded as high as $12.71 and last traded at $12.52, with a volume of 90247 shares trading hands. The stock had previously closed at $12.37. Zymeworks Stock Performance The firm has a market […]
Zymeworks Inc. (NYSE:ZYME – Get Free Report) shares hit a new 52-week high on Tuesday . The stock traded as high as $12.71 and last traded at $12.52, with a volume of 90247 shares changing hands. The stock had previously closed at $12.37. Zymeworks Stock Performance The firm has a fifty day simple moving average […]
Zymeworks Inc. (NYSE:ZYME – Get Free Report) CFO Christopher Astle sold 4,563 shares of the firm’s stock in a transaction that occurred on Friday, January 5th. The shares were sold at an average price of $10.65, for a total transaction of $48,595.95. Following the completion of the sale, the chief financial officer now owns 7,934 […]
Christopher Astle Sells 1,431 Shares of Zymeworks Inc. (NYSE:ZYME) Stock theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.
Zymeworks Inc. (NYSE:ZYME – Get Free Report) insider Paul Andrew Moore sold 2,339 shares of the firm’s stock in a transaction that occurred on Monday, January 8th. The stock was sold at an average price of $11.22, for a total transaction of $26,243.58. Following the completion of the transaction, the insider now directly owns 7,367 […]
Zymeworks Inc. (NYSE:ZYME – Get Free Report) CEO Kenneth Galbraith sold 5,706 shares of the company’s stock in a transaction on Monday, January 8th. The stock was sold at an average price of $11.22, for a total value of $64,021.32. Following the transaction, the chief executive officer now directly owns 23,762 shares in the company, […]
Christopher Astle Sells 1,431 Shares of Zymeworks Inc. (NYSE:ZYME) Stock kopsource.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from kopsource.com Daily Mail and Mail on Sunday newspapers.
Zymeworks Inc. (NYSE:ZYME – Get Free Report) insider Paul Andrew Moore sold 2,339 shares of the company’s stock in a transaction dated Monday, January 8th. The shares were sold at an average price of $11.22, for a total transaction of $26,243.58. Following the completion of the sale, the insider now directly owns 7,367 shares of […]
Zymeworks Inc. (NYSE:ZYME) CFO Christopher Astle Sells 4,563 Shares kopsource.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from kopsource.com Daily Mail and Mail on Sunday newspapers.